NRG Oncology NCORP Research Base

NRG肿瘤学NCORP研究基地

基本信息

  • 批准号:
    8902091
  • 负责人:
  • 金额:
    $ 1054.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The objective of this proposal is to establish and maintain the NCORP (National Cancer Institute Community Oncology Research Program) for the NRG Oncology research base. The NRG NCORP is the result of aligning the legacy CCOPs (Community Clinical Oncology Programs) from three NCI Cancer Cooperative Groups: NSABP, RTOG and GOG. These groups together have over almost 100 years of combined experience serving as CCOP Research Bases. NRG NCORP, comprised of a multi-disciplinary team of investigators and patient advocates, is poised to carry out the objectives of: 1) designing and conducting cancer prevention, control and screening clinical trials; 2) designing and embedding patient reported outcomes in therapeutic trials 3) designing and conducting cancer care delivery research; 4) enhancing community access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN) and 5) integrating disparity research questions into clinical trials and cancer care delivery research. To allow NRG NCORP to meet these goals, the group will: participate fully in NRG Oncology leadership and will determine the scientific direction and prioritization of the NRG NCORP activities and resources and oversee the translational research, clinical trial activities, and correlative studies related to the aims of NG NCORP. With the NRG Statistical and Data Management Center, this team will provide efficient, methodologically up-to-date trial design, monitoring, reporting, and analysis; build an infrastructure to support our cancer care delivery research agenda; provide comprehensive data management quality control and quality assurance programs to ensure high data integrity and timely data for analysis; leverage cutting edge information technology emphasizing security, timeliness, and efficiency of data collection and management; providing RT credentialing and quality assurance; and provide education and training for institutional Clinical Research Associates, Study Chairs, local Principal Investigators and others involved in the NRG NCORP research agenda. Further, to accomplish these aims NRG NCORP will engage fully with NCI-designated NCORP community physicians and patient advocates as well as the NCI and other NCl-sponsored entities (cooperative groups, cancer centers, SPOREs) to collaborate across the NCTN to improve cancer care and quality of life for patients affected by cancer.
DESCRIPTION (provided by applicant): The objective of this proposal is to establish and maintain the NCORP (National Cancer Institute Community Oncology Research Program) for the NRG Oncology research base. The NRG NCORP is the result of aligning the legacy CCOPs (Community Clinical Oncology Programs) from three NCI Cancer Cooperative Groups: NSABP, RTOG and GOG.这些团体作为 CCOP 研究基地总共拥有近 100 多年的经验。 NRG NCORP 由研究人员和患者倡导者组成的多学科团队组成,准备实现以下目标:1) 设计和开展癌症预防、控制和筛查临床试验; 2) 设计患者报告的结果并将其纳入治疗试验中 3) 设计和开展癌症护理服务研究; 4) enhancing community access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN) and 5) integrating disparity research questions into clinical trials and cancer care delivery research.为了让 NRG NCORP 实现这些目标,该小组将: 充分参与 NRG 肿瘤学的领导,确定 NRG NCORP 活动和资源的科学方向和优先顺序,并监督与 NG NCORP 目标相关的转化研究、临床试验活动和相关研究。借助 NRG 统计和数据管理中心,该团队将提供高效、方法学上最新的试验设计、监控、报告和分析;建立基础设施来支持我们的癌症护理研究议程;提供全面的数据管理质量控制和质量保证计划,以确保数据的高度完整性和及时的数据分析;利用尖端信息技术,强调数据收集和管理的安全性、及时性和效率;提供 RT 认证和质量保证;为机构临床研究员、研究主席、当地首席研究员和其他参与 NRG NCORP 研究议程的人员提供教育和培训。此外,为了实现这些目标,NRG NCORP 将与 NCI 指定的 NCORP 社区医生和患者权益倡导者以及 NCI 和其他 NCl 赞助的实体(合作团体、癌症中心、SPORE)充分合作,在 NCTN 内进行合作,以改善癌症护理和癌症患者的生活质量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deborah Watkins Bruner其他文献

Automated segmented field selection for IMRT using utility based decision theory
  • DOI:
    10.1016/s0360-3016(98)80264-2
  • 发表时间:
    1998-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Gregory E. Desobry;Deborah Watkins Bruner;Benjamin Movsas;Timothy E. Schultheiss
  • 通讯作者:
    Timothy E. Schultheiss
When Patience is a Failing: The Case for Patient Reported Outcomes Adoption
  • DOI:
    10.1016/j.ijrobp.2023.01.041
  • 发表时间:
    2023-07-15
  • 期刊:
  • 影响因子:
  • 作者:
    Deborah Watkins Bruner
  • 通讯作者:
    Deborah Watkins Bruner
Assessing women's sexuality after cancer therapy: checking assumptions with the focus group technique.
评估癌症治疗后女性的性行为:用焦点小组技术检查假设。
  • DOI:
    10.1097/00002820-199912000-00007
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Deborah Watkins Bruner;Coleen P. Boyd
  • 通讯作者:
    Coleen P. Boyd
The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Meta-analysis of Radiation Therapy Oncology Group (RTOG) Trials
性别、种族和婚姻状况对肺癌患者生存的影响:放射治疗肿瘤学组 (RTOG) 试验的荟萃分析
Associations among HPV persistence, the vaginal microbiome, and cervical cancer recurrence
  • DOI:
    10.1186/s12967-025-06811-w
  • 发表时间:
    2025-08-01
  • 期刊:
  • 影响因子:
    7.500
  • 作者:
    Despina Tsementzi;Rebecca Meador;Tony Eng;Joseph Shelton;Isabelle Scott;Konstantinos T. Konstantinidis;Susan Modesitt;Deborah Watkins Bruner
  • 通讯作者:
    Deborah Watkins Bruner

Deborah Watkins Bruner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deborah Watkins Bruner', 18)}}的其他基金

Research Training in Women's Health and Intersectionality Using Data Science and Health Information Technology (WISDOM)
利用数据科学和健康信息技术 (WISDOM) 进行妇女健康和交叉性研究培训
  • 批准号:
    10628160
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
NRG Oncology NCORP Research Base
NRG肿瘤学NCORP研究基地
  • 批准号:
    10457275
  • 财政年份:
    2014
  • 资助金额:
    $ 1054.24万
  • 项目类别:
NRG Oncology NCORP Research Base
NRG肿瘤学NCORP研究基地
  • 批准号:
    8790796
  • 财政年份:
    2014
  • 资助金额:
    $ 1054.24万
  • 项目类别:
NRG Oncology NCORP Research Base
NRG肿瘤学NCORP研究基地
  • 批准号:
    10247230
  • 财政年份:
    2014
  • 资助金额:
    $ 1054.24万
  • 项目类别:
NRG Oncology NCORP Research Base
NRG肿瘤学NCORP研究基地
  • 批准号:
    10247229
  • 财政年份:
    2014
  • 资助金额:
    $ 1054.24万
  • 项目类别:
NRG Oncology NCORP Research Base
NRG肿瘤学NCORP研究基地
  • 批准号:
    9559748
  • 财政年份:
    2014
  • 资助金额:
    $ 1054.24万
  • 项目类别:
NRG Oncology NCORP Research Base
NRG肿瘤学NCORP研究基地
  • 批准号:
    10222584
  • 财政年份:
    2014
  • 资助金额:
    $ 1054.24万
  • 项目类别:
NRG Oncology NCORP Research Base
NRG肿瘤学NCORP研究基地
  • 批准号:
    9324197
  • 财政年份:
    2014
  • 资助金额:
    $ 1054.24万
  • 项目类别:
Randomized Feasibility Study of Dilator Use and an Educational Program to Increas
扩张器使用的随机可行性研究和增加教育计划
  • 批准号:
    7706328
  • 财政年份:
    2009
  • 资助金额:
    $ 1054.24万
  • 项目类别:
Randomized Feasibility Study of Dilator Use and an Educational Program to Increas
扩张器使用的随机可行性研究和增加教育计划
  • 批准号:
    8367931
  • 财政年份:
    2009
  • 资助金额:
    $ 1054.24万
  • 项目类别:

相似海外基金

Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
  • 批准号:
    2881726
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
    Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
  • 批准号:
    10935776
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
  • 批准号:
    10649041
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
  • 批准号:
    10735964
  • 财政年份:
    2023
  • 资助金额:
    $ 1054.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了